Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Title||Drug Discovery Today|
|Abbreviation||Drug Discov. Today|
|Subject Area, Categories, Scope||Drug Discovery (Q1); Pharmacology (Q1)|
|SCImago Journal Rank (SJR)||1.397|
Drug Discovery Today is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Pharmacology (Q1). It is published by Elsevier Ltd.. The overall rank of Drug Discovery Today is 2392. According to SCImago Journal Rank (SJR), this journal is ranked 1.397. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 195. The best quartile for this journal is Q1.
The ISSN of Drug Discovery Today journal is 18785832, 13596446. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Discovery Today is cited by a total of 6129 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of Drug Discovery Today is 7.37, which is computed in 2023 as per its definition. Drug Discovery Today IS is decreased by a factor of 0.58 and approximate percentage change is -7.3% when compared to preceding year 2021, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of Drug Discovery Today is 7.37. If the same downward trend persists, impact score may fall in 2023 as well.
|Year||Impact Score (IS)|
Drug Discovery Today has an h-index of 195. It means 195 articles of this journal have more than 195 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drug Discovery Today is 18785832, 13596446. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drug Discovery Today is 2392. According to SCImago Journal Rank (SJR), this journal is ranked 1.397. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Drug Discovery Today is published by Elsevier Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1996-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drug Discovery Today is Drug Discov. Today. This abbreviation ('Drug Discov. Today') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the Drug Discovery Today is 7.37. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 7.95 (2021) and 5.72 (2015), respectively, in the last 9 years. Moreover, its average IS is 6.91 in the previous 9 years.
The Drug Discovery Today has an SJR (SCImago Journal Rank) of 1.397, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.248 in 2018 and the lowest being 1.397 in 2022. Furthermore, the average SJR of the Drug Discovery Today over the previous 9-year period stands at 6.91.
The latest h-index of the Drug Discovery Today is 195.
The Drug Discovery Today is published by the Elsevier Ltd., with its country of publication being the United Kingdom.
The Drug Discovery Today is currently ranked 2392 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1100 in 2018 and its lowest position of 2392 in 2022.
The standard ISO4 abbreviation for the Drug Discovery Today is Drug Discov. Today.
Drug Discovery Today is classified as a journal that the Elsevier Ltd. publishes.
The Drug Discovery Today encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drug Discovery Today is assigned the following International Standard Serial Numbers (ISSN): 18785832, 13596446.
The best quartile for the Drug Discovery Today is Q1 (2022).
The Drug Discovery Today coverage history can be summarized as follows: 1996-2022.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division||conference and proceedings||17477||16||0.00|
|Current Sociology||journal||6591||SAGE Publications Ltd||76||2.29|
|IEEE/OSA Journal of Display Technology||journal||12809||IEEE Computer Society||68||0.00|
|Journal of Business Finance and Accounting||journal||3221||Wiley-Blackwell Publishing Ltd||84||3.68|
|Journal of International Financial Management and Accounting||journal||6179||Wiley-Blackwell Publishing Ltd||42||6.09|
|European Surgery - Acta Chirurgica Austriaca||journal||16873||Springer Medizin||23||0.58|
|Korean Journal of Applied Microbiology and Biotechnology||journal||22033||Korean Society for Applied Microbiology||0||0.00|
|Journal of Imaging Science and Technology||journal||19249||Society for Imaging Science and Technology||44||0.96|
|European Journal of Wildlife Research||journal||8709||Springer Verlag||56||1.99|
|Transboundary and Emerging Diseases||journal||4279||Wiley-Blackwell Publishing Ltd||78||4.95|
|Year||Impact Score (IS)|